Germany's Merck wants more than just Millipore (MIL). After agreeing to buy the biotech tool...


Germany's Merck wants more than just Millipore (MIL). After agreeing to buy the biotech tool maker for $6B in cash, Merck CEO Karl-Ludwig Kley says "acquisitions are a part of our strategy," and that the company already has a few new takeover ideas.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs